Patents Represented by Attorney, Agent or Law Firm Peter J. Dehlinger
  • Patent number: 6176991
    Abstract: A serpentine electrophoresis channel, e.g., for a microchip format, is disclosed. The channel includes pairs of linear segments, e.g., parallel or right-angle segments, each joined by an angled channel region having a first curved channel portion subtending an angle &agr;f>&agr;, where &agr; is the angle between segments in a pair, and a second curved channel portion subtending an angle &agr;s=&agr;f−&agr;. The angles and cross-sections of the two channel portions are such that &dgr;tf, the time differential of analyte migration at inner and outer tracks in the first curved portion is equal to &dgr;ts, the time differential of analyte migration at outer and inner tracks in the second curved portion, respectively.
    Type: Grant
    Filed: November 12, 1998
    Date of Patent: January 23, 2001
    Assignee: The Perkin-Elmer Corporation
    Inventor: Eric S. Nordman
  • Patent number: 6165475
    Abstract: The invention provides a stable, olive-derived vegetation water substantially free of monophenolic compounds (e.g., tyrosol and its derivatives). The olive or seeds are removed from the olives prior to pressing. The pitless pulp or meat is then pressed to obtain a liquid-phase mixture including olive oil, vegetation water, and solid by-products. The vegetation water is separated from the rest of the liquid-phase mixture and collected, and stabilized for long term storage by acidification.
    Type: Grant
    Filed: January 26, 2000
    Date of Patent: December 26, 2000
    Assignee: CreAgri, Inc.
    Inventors: Roberto Crea, Luciano Caglioti
  • Patent number: 6167296
    Abstract: A surgical navigation system has a computer with a memory and display connected to a surgical instrument or pointer and position tracking system, so that the location and orientation of the pointer are tracked in real time and conveyed to the computer. The computer memory is loaded with data from an MRI, CT, or other volumetric scan of a patient, and this data is utilized to dynamically display 3-dimensional perspective images in real time of the patient's anatomy from the viewpoint of the pointer. The images are segmented and displayed in color to highlight selected anatomical features and to allow the viewer to see beyond obscuring surfaces and structures. The displayed image tracks the movement of the instrument during surgical procedures. The instrument may include an imaging device such as an endoscope or ultrasound transducer, and the system displays also the image for this device from the same viewpoint, and enables the two images to be fused so that a combined image is displayed.
    Type: Grant
    Filed: September 30, 1999
    Date of Patent: December 26, 2000
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventor: Ramin Shahidi
  • Patent number: 6165335
    Abstract: A biosensor apparatus for detecting a binding event between a ligand and receptor. The apparatus includes a biosensor surface and surface-bound two-subunit heterodimer complexes composed of first and second, preferably oppositely charged peptides that together form an .alpha.-helical coiled-coil heterodimer. The first peptide is attached to the biosensor surface, and the second peptide carries the ligand, accessible for binding by a ligand-binding agent. Binding of anti-ligand binding agent to the surface-bound ligand is detected by a suitable detector. A ligand-specific biosensor surface can be readily prepared from a universal template containing the first charged peptide, by addition of a selected ligand attached to the second peptide.
    Type: Grant
    Filed: April 24, 1997
    Date of Patent: December 26, 2000
    Assignee: Pence and McGill University
    Inventors: R. Bruce Lennox, Robert S. Hodges, Randall T. Irvin
  • Patent number: 6159712
    Abstract: Methods for enhancing the production of interferons in animal cell culture are described. These methods rely on the manipulation of the cellular levels of certain inducers of interferon production, in particular cellular levels of double-stranded-RNA-dependent kinase (dsRNA-PKR, or PKR). In cell cultures that overproduce PKR, interferon synthesis is induced to high levels, and significant amounts of interferon can be recovered without conventional induction of interferon by virus.
    Type: Grant
    Filed: November 19, 1999
    Date of Patent: December 12, 2000
    Assignee: The Regents of the University of California
    Inventor: Allan S. Lau
  • Patent number: 6140484
    Abstract: Bax-.omega. polynucleotides and polypeptides, and compositions effective to hybridize to Bax-.omega. polynucleotides are disclosed. Also disclosed are methods for altering apoptosis in cells, for promoting cell survival and for identifying compounds capable of affecting the binding of Bax-.omega. to other proteins involved in apoptosis.
    Type: Grant
    Filed: March 10, 1998
    Date of Patent: October 31, 2000
    Assignee: Elan Pharmaceuticals, Inc.
    Inventors: Catherine Mastroni Bitler, Stephen Scott Bowersox, Roberto Crea, Susan Dunham Demo, William A. Horne, Mei Zhou
  • Patent number: 6127145
    Abstract: A method for producing .alpha..sub.1 -antitrypsin (AAT) in plant cells is disclosed. Monocot plant cells transformed with an AAT coding sequence are cultivated under conditions efficient for protein expression and secretion. Also disclosed are a codon-optimized AAT coding sequence that is efficiently translated in plant cell culture and a novel AAT protein having the glycosylation pattern characteristic of plant cells and suitable for therapeutic use in humans.
    Type: Grant
    Filed: February 13, 1998
    Date of Patent: October 3, 2000
    Assignee: Applied Phytologics, Inc.
    Inventors: Thomas D. Sutliff, Raymond L. Rodriguez
  • Patent number: 6120988
    Abstract: Viral proteins derived from an enterically transmitted non-A/non-B viral hepatitis agent (HEV) are disclosed. In one embodiment, the protein is immunologically reactive with antibodies present in individuals infected with the viral hepatitis agent. This protein is useful in a diagnostic method for detecting infection by the enterically transmitted agent. Specific epitopes have been identified that are reactive with sera of individual infected with different strains of HEV. Also disclosed are DNA probes derived from a cloned sequence of the viral agent. These probes are useful for identifying and sequencing the entire viral agent and for assaying the presence of the viral agent in an infected sample, by using probe-specific amplification of virus-derived DNA fragments.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 19, 2000
    Assignees: Genelabs Technologies, Inc., The United States of America
    Inventors: Gregory R. Reyes, Patrice O. Yarbough, Daniel W. Bradley, Krzysztof Z. Krawczynski, Albert Tam, Kirk E. Fry
  • Patent number: 6114149
    Abstract: A method of amplifying a mixture of different-sequence DNA fragments which may be formed from RNA transcription, or derived from genomic single- or double-stranded DNA fragments. The fragments are treated with terminal deoxynucleotide transferase and a selected deoxynucleotide, to form a homopolymer tail at the 3' end of the anti-sense strands, and the sense strands are provided with a common 3'-end sequence. The fragments are mixed with a homopolymer primer which is homologous to the homopolymer tail of the anti-sense strands, and a defined-sequence primer which is homologous to the sense-strand common 3'-end sequence, with repeated cycles of fragment denaturation, annealing, and polymerization, to amplify the fragments. In one embodiment, the defined-sequence and homopolymer primers are the same, i.e., only one primer is used. The primers may contain selected restriction-site sequences, to provide directional restriction sites at the ends of the amplified fragments.
    Type: Grant
    Filed: August 2, 1991
    Date of Patent: September 5, 2000
    Assignee: Genelabs Technologies, Inc.
    Inventors: Kirk Fry, James Larrick, Albert Tam
  • Patent number: 6107023
    Abstract: A method of isolating genomic or RNA-derived duplex fragments which are unique to one of two fragment mixtures. The fragments in positive-source and negative-source mixtures are separately equipped with end linkers, and each mixture is amplified by successive primed-strand replications, using a single primer which is homologous to the associated linker. The second-source linker is biotinylated, and the fragments in this mixture are hybridized in molar excess with the fragments in the positive-source mixture. DNA species which are not hybridized with the biotinylated species, i.e., species that are unique to the positive-source mixture, are isolated after removal of hybridized species by affinity chromatography. Also disclosed is a method of amplifying a mixture of DNA fragments by repeated linker/primer replication.
    Type: Grant
    Filed: June 17, 1988
    Date of Patent: August 22, 2000
    Assignee: Genelabs Technologies, Inc.
    Inventors: Gregory R. Reyes, Jungsuh Kim
  • Patent number: 6107102
    Abstract: A suspension of microfabricated microdevices for use in therapeutic applications is disclosed. The microdevices have a selected shape, and uniform dimensions preferably in the 100 nm to 10 Am range. Also disclosed are microfabrication methods for making such microdevices.
    Type: Grant
    Filed: August 7, 1997
    Date of Patent: August 22, 2000
    Assignee: Regents of the University of California
    Inventor: Mauro Ferrari
  • Patent number: 6099857
    Abstract: A lipid vesicle composition for use in delivering a vesicle-encapsulated agent to a target cell is disclosed. The composition is formed of vesicle-forming lipids, including at least 10 mole percent plasmalogen phospholipid with a small-volume polar head group. The composition may also include a fusion protein for promoting fusion of the vesicles to the target cells. A novel fusion protein identified as an isoform of glyceraldehyde-3-phosphate dehydrogenase is also disclosed.
    Type: Grant
    Filed: June 5, 1998
    Date of Patent: August 8, 2000
    Assignee: Washington University
    Inventor: Richard W. Gross
  • Patent number: 6100447
    Abstract: A method for stably transforming barley from mature barley seeds as starting material is disclosed. The method involves germinating mature barley seeds until early shoot development occurs, exposing scutellar or embryo tissue cells on the embryo side of germinated seeds, and introducing foreign DNA into the cells. The cells are initially grown under conditions that allow expression of a selectable marker introduced with the foreign DNA, then on a callus-growth medium effective to suppress callus formation in the absence of the selectable marker. Successfully transformed calli can be cultured in suspension to obtain a desired foreign protein, or regenerated into plants, to obtain the foreign protein from the transformed plants, e.g., germinated seeds.
    Type: Grant
    Filed: February 12, 1998
    Date of Patent: August 8, 2000
    Assignee: Applied Phytologics, Inc.
    Inventors: Liying Wu, Raymond L. Rodriguez
  • Patent number: 6066781
    Abstract: A chimeric gene for use in producing a mature protein in secreted form by stably transformed plant cells is disclosed. The gene includes a DNA coding sequence encoding a fusion protein having an (i) N-terminal moiety corresponding to the portion of the rice .alpha.-amylase signal sequence peptide identified by SEQ ID: 1 and, (ii) immediately adjacent the C-terminal amino acid of said portion, a protein moiety corresponding to the protein to be produced. Also disclosed are a fusion protein encoded by the gene, and a method of producing a mature protein in secreted form by plant cells.
    Type: Grant
    Filed: February 13, 1998
    Date of Patent: May 23, 2000
    Assignee: Applied Phytologics, Inc.
    Inventors: Thomas D. Sutliff, Raymond L. Rodriguez
  • Patent number: 6043094
    Abstract: A method of liposome-based therapy for a mammalian subject is disclosed. The method uses liposomes with outer surfaces that contain an affinity moiety effective to bind specifically to a biological surface at which the therapy is aimed, and a hydrophilic polymer coating effective to shield the affinity moiety from interaction with the target surface. The hydrophilic polymer coating is made up of polymer chains covalently linked to surface lipid components in the liposomes through releasable linkages. After a desired liposome biodistribution is achieved, a releasing agent is administered to cause cleaving of a substantial portion of the releasable linkages in the liposomes, to expose the affinity agent to the target surface.
    Type: Grant
    Filed: October 10, 1997
    Date of Patent: March 28, 2000
    Assignee: Sequus Pharmaceuticals, Inc.
    Inventors: Francis J. Martin, Samuel Zalipsky, Shi Kun Huang
  • Patent number: 6030956
    Abstract: A method of treating cancer in a subject, by administering to the subject a combination of genes including wt p53, Pax5 and HSV-tk genes is disclosed. The method may involve subsequently treating the subject with ganciclovir.
    Type: Grant
    Filed: October 23, 1997
    Date of Patent: February 29, 2000
    Inventor: Teni Boulikas
  • Patent number: 6019789
    Abstract: A unit cell for use in a medical device, such as a stent, is disclosed along with a description of a stent formed from a plurality of unit cells and for use in the treatment of restenosis or other vascular narrowing. The unit cell is designed and configured for uniform radial expansion with minimal axial shortening and recoil, and is selectively variable in flexibility and expendability.
    Type: Grant
    Filed: April 1, 1998
    Date of Patent: February 1, 2000
    Assignee: Quanam Medical Corporation
    Inventors: Linh A. Dinh, Loc X. Phan, Robert Eury, Irina Pomerantseva, Michael Froix
  • Patent number: 6015843
    Abstract: A method of preparing an aqueous suspension of organosilanized colloidal silica particles is disclosed. Such particles are used in a variety of applications including density gradient separation media, anti-abrasion coatings and toner materials. The disclosed process is environmentally safe and produces a product that is aqueous and non-toxic to most biological cells.
    Type: Grant
    Filed: January 14, 1998
    Date of Patent: January 18, 2000
    Assignee: Dendreon Corporation
    Inventors: Peter Van Vlasselaer, Shirin W. Hasan
  • Patent number: 5994628
    Abstract: This invention provides for the secretion of heterologous protein in plant systems. In particular, this invention provides for the production of heterologous proteins by malting of monocot plant seeds. The heterologous genes are expressed during germination of the seeds and isolated from a malt. Also disclosed are chimeric genes, vectors and methods relating to the present invention. Protein production by cell culture techniques is also described.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: November 30, 1999
    Assignee: The Regents of the University of California
    Inventor: Raymond L. Rodriguez
  • Patent number: 5994305
    Abstract: A method of producing analgesia in nociceptive and neuropathic pain is disclosed. The method includes administering to a subject an omega conopeptide which is characterized by its ability to (a) inhibit electrically stimulated contraction of the guinea pig ileum, and (b) bind selectively to omega conopeptide MVIIA binding sites present in neuronal tissue. Also disclosed are novel omega conotoxin peptides effective in producing analgesia.
    Type: Grant
    Filed: August 21, 1998
    Date of Patent: November 30, 1999
    Assignee: Elan Pharmaceuticals, Inc.
    Inventors: Alan Justice, Tejinder Singh, Kishor Chandra Gohil, Karen L. Valentino, George P. Miljanich